These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29336367)

  • 1. Reduction of Tat-interacting Protein 30 Expression Could be a Prognostic Marker in Bladder Urothelial Cancer.
    Li YP; Zhu JF; Huang KT; Wang RR; Cai B; Xie H; Chen HD
    Chin Med J (Engl); 2018 Jan; 131(2):188-193. PubMed ID: 29336367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and function analysis of indoleamine 2 and 3-dioxygenase in bladder urothelial carcinoma.
    Yang C; Zhou Y; Zhang L; Jin C; Li M; Ye L
    Int J Clin Exp Pathol; 2015; 8(2):1768-75. PubMed ID: 25973066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator.
    Inoue S; Mizushima T; Fujita K; Meliti A; Ide H; Yamaguchi S; Fushimi H; Netto GJ; Nonomura N; Miyamoto H
    Hum Pathol; 2017 Jun; 64():83-90. PubMed ID: 28428106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell immunoglobulin mucin-3 expression in bladder urothelial carcinoma: Clinicopathologic correlations and association with survival.
    Yang M; Yu Q; Liu J; Fu W; Cao Y; Yu L; Shao S; Wang X; Niu H; Wang Y
    J Surg Oncol; 2015 Sep; 112(4):430-5. PubMed ID: 26265374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of transcription factor Twist1 in bladder urothelial carcinoma and its clinical significance.
    Tang X; Xing J; Li W; Wu Z; Zhang K; Zheng J
    J BUON; 2013; 18(1):211-9. PubMed ID: 23613408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated preoperative plasma fibrinogen level is an independent predictor of malignancy and advanced stage disease in patients with bladder urothelial tumors.
    Liu J; Li D; Cao L; Wang Z; Li Y; Liu H; Chen G
    Int J Surg; 2016 Dec; 36(Pt A):249-254. PubMed ID: 27826047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sp1 is overexpressed and associated with progression and poor prognosis in bladder urothelial carcinoma patients.
    Zhu J; Lu Z; Ke M; Cai X
    Int Urol Nephrol; 2022 Jul; 54(7):1505-1512. PubMed ID: 35467245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients.
    Guo S; Jing W; Hu X; Zhou X; Liu L; Zhu M; Yin F; Chen R; Zhao J; Guo Y
    Int J Cancer; 2014 Mar; 134(6):1369-78. PubMed ID: 24037692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer.
    Poyet C; Buser L; Roudnicky F; Detmar M; Hermanns T; Mannhard D; Höhn A; Rüschoff J; Zhong Q; Sulser T; Moch H; Wild PJ
    J Clin Pathol; 2015 Oct; 68(10):819-24. PubMed ID: 26251520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of TIP30 correlates with poor prognosis of gastric cancer patients and its restoration drastically inhibits tumor growth and metastasis.
    Li X; Zhang Y; Cao S; Chen X; Lu Y; Jin H; Sun S; Chen B; Liu J; Ding J; Wu K; Fan D
    Int J Cancer; 2009 Feb; 124(3):713-21. PubMed ID: 18972434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adenosine A2b receptor promotes tumor progression of bladder urothelial carcinoma by enhancing MAPK signaling pathway.
    Zhou Y; Chu X; Deng F; Tong L; Tong G; Yi Y; Liu J; Tang J; Tang Y; Xia Y; Dai Y
    Oncotarget; 2017 Jul; 8(30):48755-48768. PubMed ID: 28548944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
    Chang WC; Chang YH; Pan CC
    Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy.
    Holmäng S; Andius P; Hedelin H; Wester K; Busch C; Johansson SL
    J Urol; 2001 Apr; 165(4):1124-8; discussion 1128-30. PubMed ID: 11257652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-κB/MMP-7 signaling pathway.
    Liu JY; Dai YB; Li X; Cao K; Xie D; Tong ZT; Long Z; Xiao H; Chen MK; Ye YL; Liu B; Tan J; Tang J; Xu ZZ; Gan Y; Zhou YH; Deng F; He LY
    Cell Death Dis; 2017 Mar; 8(3):e2691. PubMed ID: 28333147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Checkpoint Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 is Upregulated and Independently Predicts Unfavorable Prognosis in Bladder Urothelial Carcinoma.
    Lin G; Ye H; Wang J; Chen S; Chen X; Zhang C
    Nephron; 2019; 141(4):256-264. PubMed ID: 30602154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combination of p40, GATA-3 and uroplakin II shows utility in the diagnosis and prognosis of muscle-invasive urothelial carcinoma.
    Leivo MZ; Elson PJ; Tacha DE; Delahunt B; Hansel DE
    Pathology; 2016 Oct; 48(6):543-9. PubMed ID: 27594510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological and immunohistochemical markers for progression prediction in transurethrally resected high-grade non-muscle invasive bladder cancer.
    Kim K; Cho YM; Park BH; Lee JL; Ro JY; Go H; Shim JW
    Int J Clin Exp Pathol; 2015; 8(1):743-50. PubMed ID: 25755769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMP3 predicts aggressive superficial urothelial carcinoma of the bladder.
    Sitnikova L; Mendese G; Liu Q; Woda BA; Lu D; Dresser K; Mohanty S; Rock KL; Jiang Z
    Clin Cancer Res; 2008 Mar; 14(6):1701-6. PubMed ID: 18347170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein expression and amplification of AIB1 in human urothelial carcinoma of the bladder and overexpression of AIB1 is a new independent prognostic marker of patient survival.
    Luo JH; Xie D; Liu MZ; Chen W; Liu YD; Wu GQ; Kung HF; Zeng YX; Guan XY
    Int J Cancer; 2008 Jun; 122(11):2554-61. PubMed ID: 18246597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Snail is an independent prognostic indicator for predicting recurrence and progression in non-muscle-invasive bladder cancer.
    Gou Y; Ding W; Xu K; Wang H; Chen Z; Tan J; Xia G; Ding Q
    Int Urol Nephrol; 2015 Feb; 47(2):289-93. PubMed ID: 25388353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.